NM_016038.4:c.127G>T

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 2P and 6B. PM1BP4_StrongBP6BS2_Supporting

The NM_016038.4(SBDS):​c.127G>T​(p.Val43Leu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00142 in 1,613,556 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00099 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0015 ( 2 hom. )

Consequence

SBDS
NM_016038.4 missense, splice_region

Scores

1
9
9
Splicing: ADA: 0.7986
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: 2.73

Publications

7 publications found
Variant links:
Genes affected
SBDS (HGNC:19440): (SBDS ribosome maturation factor) This gene encodes a highly conserved protein that plays an essential role in ribosome biogenesis. The encoded protein interacts with elongation factor-like GTPase 1 to disassociate eukaryotic initiation factor 6 from the late cytoplasmic pre-60S ribosomal subunit allowing assembly of the 80S subunit. Mutations within this gene are associated with the autosomal recessive disorder Shwachman-Bodian-Diamond syndrome. This gene has a closely linked pseudogene that is distally located. [provided by RefSeq, Jan 2017]
TYW1 (HGNC:25598): (tRNA-yW synthesizing protein 1 homolog) Wybutosine (yW) is a hypermodified guanosine found in phenylalanine tRNA adjacent to the anticodon that stabilizes codon-anticodon interactions in the ribosome. In yeast, the homolog of this gene is essential for the synthesis of wybutosine. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

PM1
In a chain Ribosome maturation protein SBDS (size 248) in uniprot entity SBDS_HUMAN there are 12 pathogenic changes around while only 1 benign (92%) in NM_016038.4
BP4
Computational evidence support a benign effect (MetaRNN=0.04228115).
BP6
Variant 7-66995291-C-A is Benign according to our data. Variant chr7-66995291-C-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 378498.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=2, Likely_benign=1}.
BS2
High Homozygotes in GnomAdExome4 at 2 AR geneVariant has number of homozygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SBDSNM_016038.4 linkc.127G>T p.Val43Leu missense_variant, splice_region_variant Exon 1 of 5 ENST00000246868.7 NP_057122.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SBDSENST00000246868.7 linkc.127G>T p.Val43Leu missense_variant, splice_region_variant Exon 1 of 5 1 NM_016038.4 ENSP00000246868.2 Q9Y3A5

Frequencies

GnomAD3 genomes
AF:
0.000992
AC:
151
AN:
152250
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000384
Gnomad SAS
AF:
0.000620
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00193
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00117
AC:
293
AN:
251058
AF XY:
0.00113
show subpopulations
Gnomad AFR exome
AF:
0.000124
Gnomad AMR exome
AF:
0.000434
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.000647
Gnomad NFE exome
AF:
0.00223
Gnomad OTH exome
AF:
0.000979
GnomAD4 exome
AF:
0.00146
AC:
2138
AN:
1461188
Hom.:
2
Cov.:
31
AF XY:
0.00147
AC XY:
1068
AN XY:
726906
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000179
AC:
6
AN:
33462
American (AMR)
AF:
0.000470
AC:
21
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26128
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39694
South Asian (SAS)
AF:
0.000267
AC:
23
AN:
86232
European-Finnish (FIN)
AF:
0.000655
AC:
35
AN:
53402
Middle Eastern (MID)
AF:
0.000366
AC:
2
AN:
5464
European-Non Finnish (NFE)
AF:
0.00179
AC:
1985
AN:
1111756
Other (OTH)
AF:
0.00104
AC:
63
AN:
60330
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.365
Heterozygous variant carriers
0
96
192
289
385
481
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000991
AC:
151
AN:
152368
Hom.:
0
Cov.:
33
AF XY:
0.000913
AC XY:
68
AN XY:
74516
show subpopulations
African (AFR)
AF:
0.000192
AC:
8
AN:
41590
American (AMR)
AF:
0.0000653
AC:
1
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000385
AC:
2
AN:
5192
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4834
European-Finnish (FIN)
AF:
0.000471
AC:
5
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00193
AC:
131
AN:
68032
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
9
17
26
34
43
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00107
Hom.:
0
Bravo
AF:
0.000839
ExAC
AF:
0.00151
AC:
183
EpiCase
AF:
0.00158
EpiControl
AF:
0.00172

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:3
-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

The SBDS p.Val43Leu variant was identified in 1 of 240 proband chromosomes (frequency: 0.0042) from individuals with primary hypocellular refractory cytopenia (Karow_2010_PMID:19951977). The variant was also reported as a heterozygous variant in a girl with cystic fibrosis and Shwachman-Bodian-Diamond Syndrome as a variant of unknown clinical significance (Thomassen_2016). The variant was identified in dbSNP (ID: rs147652512) LOVD 3.0 and ClinVar (classified as likely benign by GeneDx). The variant was identified in control databases in 302 of 268098 chromosomes (1 homozygous) at a frequency of 0.001126 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: European (non-Finnish) in 254 of 118020 chromosomes (freq: 0.002152), Other in 8 of 6704 chromosomes (freq: 0.001193), European (Finnish) in 16 of 25094 chromosomes (freq: 0.000638), Latino in 15 of 35098 chromosomes (freq: 0.000427), African in 4 of 23554 chromosomes (freq: 0.00017), East Asian in 3 of 19246 chromosomes (freq: 0.000156) and South Asian in 2 of 30526 chromosomes (freq: 0.000066), but was not observed in the Ashkenazi Jewish population. The p.Val43 residue is not conserved in mammals and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The p.Val43Leu variant occurs in the second last base of the exon; this position has been shown to be part of the splicing consensus sequence and variants involving this position sometimes affect splicing. However, three of four in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a greater than 10% difference in splicing. Further, transcriptional studies did not reveal an effect on splicing due to this variant (Karow_2010_PMID:19951977). In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -

Mar 19, 2021
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 03, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Observed with a pathogenic variant on the opposite allele (in trans) in a patient with Diamond-Blackfan anemia in published literature (PMID: 26136524, 31839986); Observed in the heterozygous state with no second SBDS variant in patients with refractory cytopenia or suspected Shwachman-Diamond syndrome (PMID: 19951977, 34151701, Thomassen JC et al., 2016); In silico analysis suggests that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 26136524, 31839986, 34151701, 36835434, 19951977, Thomassen2016[CaseReport], 40249815) -

not specified Benign:1
Aug 09, 2020
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.40
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Uncertain
-0.050
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.66
D
Eigen
Benign
-0.10
Eigen_PC
Benign
0.026
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Pathogenic
0.98
D
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.042
T
MetaSVM
Uncertain
0.29
D
MutationAssessor
Benign
1.8
L
PhyloP100
2.7
PrimateAI
Uncertain
0.73
T
PROVEAN
Benign
-1.6
N
REVEL
Uncertain
0.41
Sift
Benign
0.12
T
Sift4G
Benign
0.18
T
Polyphen
0.0
B
Vest4
0.16
MutPred
0.31
Loss of MoRF binding (P = 0.1008);
MVP
0.92
MPC
0.43
ClinPred
0.069
T
GERP RS
3.3
PromoterAI
0.012
Neutral
Varity_R
0.35
gMVP
0.47
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.80
dbscSNV1_RF
Benign
0.55
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147652512; hg19: chr7-66460278; COSMIC: COSV55887716; COSMIC: COSV55887716; API